News and Events Recent News Jan 22, 2020 Arrowhead Pharmaceuticals to Webcast Fiscal 2020 First Quarter Results Jan 6, 2020 Arrowhead Pharmaceuticals Appoints James Hassard as Chief Commercial Officer Dec 20, 2019 Arrowhead Pharmaceuticals Doses First Patient in AROAAT2002 Open Label Phase 2 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease View More » Recent Events Feb 5, 2020 Arrowhead Pharmaceuticals 2020 First Quarter Results Dec 11, 2019 HEP DART 2019 Dec 3, 2019 Piper Jaffray 31st Annual Healthcare Conference View More »
Dec 20, 2019 Arrowhead Pharmaceuticals Doses First Patient in AROAAT2002 Open Label Phase 2 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease